The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[6-amino-4-(trifluoromethyl)-3-pyridyl]-N-[2-(dimethylamino)ethyl]-7-methyl-4-morpholino-pyrrolo[2,1-f][1,2,4]triazine-6-carboxamide ID: ALA4646999
PubChem CID: 156020800
Max Phase: Preclinical
Molecular Formula: C22H27F3N8O2
Molecular Weight: 492.51
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1c(C(=O)NCCN(C)C)cc2c(N3CCOCC3)nc(-c3cnc(N)cc3C(F)(F)F)nn12
Standard InChI: InChI=1S/C22H27F3N8O2/c1-13-14(21(34)27-4-5-31(2)3)10-17-20(32-6-8-35-9-7-32)29-19(30-33(13)17)15-12-28-18(26)11-16(15)22(23,24)25/h10-12H,4-9H2,1-3H3,(H2,26,28)(H,27,34)
Standard InChI Key: ZAJQIEXPUWHQTA-UHFFFAOYSA-N
Molfile:
RDKit 2D
35 38 0 0 0 0 0 0 0 0999 V2000
32.3808 -15.8221 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.0929 -15.4107 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8012 -15.8215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.8012 -16.6451 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.0955 -17.0557 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3808 -16.6462 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6736 -17.0551 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.5083 -17.0540 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2196 -16.6451 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
34.5083 -17.8717 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
35.2196 -17.4628 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
34.5134 -15.4097 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5137 -14.5902 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.2234 -14.1811 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9359 -14.5931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9382 -15.4108 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.2299 -15.8240 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.7160 -15.6612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1964 -14.9986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7125 -14.3385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0142 -14.9986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4231 -14.2915 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.2408 -14.2915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6497 -13.5802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4674 -13.5802 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
40.8722 -12.8731 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.8722 -14.2915 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.4231 -15.7058 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.9266 -16.4476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2234 -13.3633 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.5163 -12.9545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5163 -12.1368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2235 -11.7279 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
35.9306 -12.1368 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9306 -12.9545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
6 7 1 0
4 8 1 0
8 9 1 0
8 10 1 0
8 11 1 0
12 3 1 0
13 12 1 0
14 13 2 0
15 14 1 0
16 15 1 0
17 16 1 0
12 17 2 0
16 18 1 0
19 18 2 0
20 19 1 0
15 20 2 0
19 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
25 27 1 0
21 28 2 0
18 29 1 0
14 30 1 0
31 30 1 0
32 31 1 0
33 32 1 0
34 33 1 0
35 34 1 0
30 35 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 492.51Molecular Weight (Monoisotopic): 492.2209AlogP: 1.83#Rotatable Bonds: 6Polar Surface Area: 113.91Molecular Species: BASEHBA: 9HBD: 2#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 8.51CX LogP: 2.48CX LogD: 1.34Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.54Np Likeness Score: -1.50
References 1. Xiang HY, Chen YH, Wang Y, Zhang X, Ding J, Meng LH, Yang CH.. (2020) Design, synthesis and antiproliferative activity evaluation of a series of pyrrolo[2,1-f][1,2,4]triazine derivatives., 30 (12): [PMID:32317209 ] [10.1016/j.bmcl.2020.127194 ]